Long-term use of systemic hormone replacement therapy may slightly increase the risk of developing Alzheimer disease.
As dyspareunia may cause distress or interpersonal conflict between women and their partners, healthcare providers should routinely ask about discomfort during intercourse, especially in menopausal patients.
Elderly men are significantly undertreated for osteoporosis.
Helicobacter pylori infection is associated with a higher risk for type 2 diabetes developing.
Reduced risk seen for type 2 diabetes after adjustment for confounders.
AUC 0.722 for predicting prevalent diabetes in test dataset; negative predictive value 97%.
Menopause symptoms are associated with chronic pain among midlife female veterans.
Sustained increase in physical activity, decrease in sedentary time seen with behavioral intervention.
Integrated intervention associated with decline in body mass index, depressive symptoms.
The immune response to vaccinations is lower in children who are obese compared with nonobese children.
Statin use in elderly women with coronary artery disease may prevent bone loss.
Achievement rates for all 3 targets and for HbA1c, BP, LDL-C are lowest in the winter.
Findings show weight loss from intervention regardless of an individual’s diabetes status.
But program has unintended consequence of increasing incidence, prevalence of obesity.
In postmenopausal women, low optimism, high negative emotional expressiveness, and hostility are associated with an increased risk for type 2 diabetes.
Higher consumption of nuts, especially tree nuts, is associated with reduced cardiovascular disease incidence and mortality among patients with type 2 diabetes.
Among postmenopausal women, consumption of artificially sweetened beverages is associated with an increased risk for stroke, coronary heart disease, and all-cause mortality.
The AACE and ACE published an annual update to their joint type 2 diabetes management algorithm.
Product works by delivering insulin under the skin at set or variable rates.
For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for adverse events during premaintenance chemotherapy.